Publication | Closed Access

In vitro sustained release of bioactive anti-NogoA, a molecule in clinical development for treatment of spinal cord injury

Regenerative MedicineNeuroregenerationSpinal Cord InjuryMedicineSpinal TraumaBioactive Anti-nogoaClinical DevelopmentPharmacotherapyWound HealingNeuroprotectionPharmacologySpinal Disorder